IMAAVY

Formula & Concentration

IMAAVY- nipocalimab injection, solution, concentrate

Manufacturer

Jom Pharmaceutical Services Inc.

Indications

IMAAVY is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients 12 years of age and older who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.

Product Options

Package Size

NDC #

Presentation

1200 mg

300 mg

57894-0801-01

57894-0800-01

Vial

Vial

Shelf Life and Storage

Store vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until the time of use. Do not freeze. Do not shake.